Ceramide content is increased in skeletal muscle from obese insulin-resistant humans
- PMID: 14693694
- DOI: 10.2337/diabetes.53.1.25
Ceramide content is increased in skeletal muscle from obese insulin-resistant humans
Abstract
Increased intramyocellular lipid concentrations are thought to play a role in insulin resistance, but the precise nature of the lipid species that produce insulin resistance in human muscle are unknown. Ceramides, either generated via activation of sphingomyelinase or produced by de novo synthesis, induce insulin resistance in cultured cells by inhibitory effects on insulin signaling. The present study was undertaken to determine whether ceramides or other sphingolipids are increased in muscle from obese insulin-resistant subjects and to assess whether ceramide plays a role in the insulin resistance of Akt in human muscle. Lean insulin-sensitive and obese insulin-resistant subjects (n = 10 each) received euglycemic-hyperinsulinemic clamps with muscle biopsies basally and after 30, 45, or 60 min of insulin infusion. The rate of glucose infusion required to maintain euglycemia (reflecting glucose uptake) was reduced by >50%, as expected, in the obese subjects at each time point (P < 0.01). Under basal conditions, total muscle ceramide content was increased nearly twofold in the obese subjects (46 +/- 9 vs. 25 +/- 2 pmol/2 mg muscle, P < 0.05). All species of ceramides were increased similarly in the obese subjects; in contrast, no other sphingolipid was increased. Stimulation of Akt phosphorylation by insulin in the obese subjects was significantly reduced after 30 min (0.96 +/- 0.11 vs. 1.84 +/- 0.38 arbitrary units) or 45-60 min (0.68 +/- 0.17 vs. 1.52 +/- 0.26) of insulin infusion (P < 0.05 for both). Muscle ceramide content was significantly correlated with the plasma free fatty acid concentration (r = 0.51, P < 0.05). We conclude that obesity is associated with increased intramyocellular ceramide content. This twofold increase in ceramide may be involved in the decrease in Akt phosphorylation observed after insulin infusion and could theoretically play a role in the reduced ability of insulin to stimulate glucose uptake in skeletal muscle from obese subjects.
Similar articles
-
Effect of gender on lipid-induced insulin resistance in obese subjects.Eur J Endocrinol. 2008 Jan;158(1):61-8. doi: 10.1530/EJE-07-0493. Eur J Endocrinol. 2008. PMID: 18166818 Clinical Trial.
-
Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.Diabetes. 2017 Aug;66(8):2082-2091. doi: 10.2337/db17-0082. Epub 2017 May 8. Diabetes. 2017. PMID: 28483801 Free PMC article.
-
Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects.J Clin Endocrinol Metab. 2007 Apr;92(4):1524-9. doi: 10.1210/jc.2006-2347. Epub 2007 Jan 30. J Clin Endocrinol Metab. 2007. PMID: 17264178
-
Influence of Exercise Training on Skeletal Muscle Insulin Resistance in Aging: Spotlight on Muscle Ceramides.Int J Mol Sci. 2020 Feb 22;21(4):1514. doi: 10.3390/ijms21041514. Int J Mol Sci. 2020. PMID: 32098447 Free PMC article. Review.
-
Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes.Front Endocrinol (Lausanne). 2021 Mar 18;12:635175. doi: 10.3389/fendo.2021.635175. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33815291 Free PMC article. Review.
Cited by
-
Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases.Antioxidants (Basel). 2023 Dec 8;12(12):2091. doi: 10.3390/antiox12122091. Antioxidants (Basel). 2023. PMID: 38136211 Free PMC article. Review.
-
Metabolite profiles of diabetes mellitus and response to intervention in anti-hyperglycemic drugs.Front Endocrinol (Lausanne). 2023 Oct 31;14:1237934. doi: 10.3389/fendo.2023.1237934. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027178 Free PMC article. Review.
-
Both moderate- and high-intensity exercise training increase intramyocellular lipid droplet abundance and modify myocellular distribution in adults with obesity.Am J Physiol Endocrinol Metab. 2023 Nov 1;325(5):E466-E479. doi: 10.1152/ajpendo.00093.2023. Epub 2023 Sep 20. Am J Physiol Endocrinol Metab. 2023. PMID: 37729021
-
Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes.Rev Endocr Metab Disord. 2023 Oct;24(5):921-936. doi: 10.1007/s11154-023-09821-5. Epub 2023 Jul 5. Rev Endocr Metab Disord. 2023. PMID: 37402955 Free PMC article. Review.
-
Noncanonical Regulation of cAMP-Dependent Insulin Secretion and Its Implications in Type 2 Diabetes.Compr Physiol. 2023 Jun 26;13(3):5023-5049. doi: 10.1002/cphy.c220031. Compr Physiol. 2023. PMID: 37358504 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical